
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.45 | 0.45 | 0.00 |
Shares | 99.55 | 99.55 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.88 | 19.13 |
Price to Book | 3.49 | 4.31 |
Price to Sales | 2.51 | 2.41 |
Price to Cash Flow | 14.28 | 16.61 |
Dividend Yield | 1.66 | 1.14 |
5 Years Earnings Growth | 14.78 | 12.06 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.63 | 99.62 |
Financial Services | 1.92 | 0.63 |
Communication Services | 0.69 | 0.71 |
Consumer Defensive | 0.60 | 0.45 |
Basic Materials | 0.12 | 1.02 |
Technology | 0.04 | 0.16 |
Number of long holdings: 110
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.50 | 750.78 | +0.49% | |
Boston Scientific | US1011371077 | 5.35 | 103.10 | -1.03% | |
UnitedHealth | US91324P1021 | 4.90 | 301.22 | -1.15% | |
Regeneron Pharma | US75886F1075 | 4.46 | 487.86 | -0.60% | |
Merck&Co | US58933Y1055 | 4.17 | 77.14 | +1.17% | |
Pfizer | US7170811035 | 4.11 | 23.35 | -0.47% | |
Chugai Pharmaceutical | JP3519400000 | 3.96 | 7,416.0 | -1.08% | |
AbbVie | US00287Y1091 | 3.69 | 187.25 | +0.14% | |
Amgen | US0311621009 | 3.66 | 289.57 | +0.38% | |
Roche Holding Participation | CH0012032048 | 3.62 | 263.80 | -0.34% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Delaware Small Cap Core I | 5.25B | -11.48 | 2.70 | 7.09 | ||
Delaware Emerging Markets Instl | 2.86B | 3.39 | 4.53 | 4.81 | ||
Delaware Small Cap Value Instl | 2.25B | -8.70 | 2.70 | 6.49 | ||
Optimum Large Cap Growth Instl | 1.87B | -9.37 | 13.76 | 12.04 | ||
Optimum Large Cap Value Instl | 1.8B | -1.08 | 7.87 | 7.89 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review